News

This report maps the available and pipeline diagnostics to detect and identify WHO bacterial priority pathogens and to perform phenotypic antimicrobial susceptibility testing (AST) or genotypic testing for antibacterial resistance, identifies gaps in the availability of, and access to, such diagnostics, and establishes a WHO research and development (R&D) priority list of diagnostics for further development that could be available for use across a variety of settings globally in the next three to five years.